Legal & General Group
CLB icon

Legal & General Group’s Core Laboratories CLB Stock Holding History

Legal & General Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
122,575
+3,397
+3% +$48.5K ﹤0.01% 2080
2026
Q1 		$2M Sell
119,178
-9,612
-7% -$172K ﹤0.01% 1906
2025
Q4 		$2.06M Sell
128,790
-9,169
-7% -$136K ﹤0.01% 1953
2025
Q3 		$1.71M Sell
137,959
-2,890
-2% -$33.9K ﹤0.01% 2047
2025
Q2 		$1.62M Buy
140,849
+362
+0.3% +$4.29K ﹤0.01% 2046
2025
Q1 		$2.11M Sell
140,487
-4,792
-3% -$80.2K ﹤0.01% 1901
2024
Q4 		$2.51M Buy
145,279
+347
+0.2% +$6.7K ﹤0.01% 1878
2024
Q3 		$2.69M Sell
144,932
-1,468
-1% -$29.5K ﹤0.01% 1849
2024
Q2 		$2.97M Buy
146,400
+145,790
+23,900% +$2.58M ﹤0.01% 1772
2024
Q1 		$10.4K Hold
610
– – ﹤0.01% 3191
2023
Q4 		$10.7K Hold
610
– – ﹤0.01% 3224
2023
Q3 		$14.6K Buy
+610
New +$15K ﹤0.01% 3158
2023
Q2 		– Sell
-133,350
Closed -$2.94M – 3434
2023
Q1 		$2.94M Buy
133,350
+5,472
+4% +$128K ﹤0.01% 1694
2022
Q4 		$2.59M Buy
127,878
+2,588
+2% +$50.2K ﹤0.01% 1752
2022
Q3 		$1.69M Sell
125,290
-3,834
-3% -$64.6K ﹤0.01% 1949
2022
Q2 		$2.56M Buy
129,124
+5,814
+5% +$154K ﹤0.01% 1756
2022
Q1 		$3.9M Sell
123,310
-1,005
-0.8% -$28.2K ﹤0.01% 1664
2021
Q4 		$2.77M Buy
124,315
+3,183
+3% +$83K ﹤0.01% 1868
2021
Q3 		$3.36M Sell
121,132
-2,108
-2% -$64.2K ﹤0.01% 1750
2021
Q2 		$4.8M Sell
123,240
-26,573
-18% -$953K ﹤0.01% 1549
2021
Q1 		$4.31M Buy
149,813
+6,244
+4% +$213K ﹤0.01% 1638
2020
Q4 		$3.81M Sell
143,569
-2,472
-2% -$50.5K ﹤0.01% 1604
2020
Q3 		$2.23M Buy
146,041
+8,706
+6% +$183K ﹤0.01% 1719
2020
Q2 		$2.79M Buy
137,335
+82,941
+152% +$1.49M ﹤0.01% 1586
2020
Q1 		$563K Buy
54,394
+2,300
+4% +$64.3K ﹤0.01% 2036
2019
Q4 		$1.96M Buy
52,094
+711
+1% +$31.9K ﹤0.01% 1807
2019
Q3 		$2.4M Buy
51,383
+1,507
+3% +$70.1K ﹤0.01% 1642
2019
Q2 		$2.61M Sell
49,876
-2,661
-5% -$156K ﹤0.01% 1580
2019
Q1 		$3.62M Sell
52,537
-120,348
-70% -$8.07M ﹤0.01% 1392
2018
Q4 		$10.3M Buy
172,885
+2,589
+2% +$223K 0.01% 829
2018
Q3 		$19.7M Buy
170,296
+1,250
+0.7% +$141K 0.01% 728
2018
Q2 		$21.3M Sell
169,046
-6,349
-4% -$773K 0.02% 708
2018
Q1 		$19M Sell
175,395
-31,355
-15% -$3.47M 0.01% 720
2017
Q4 		$22.6M Sell
206,750
-6,559
-3% -$655K 0.02% 660
2017
Q3 		$21.1M Buy
213,309
+23,416
+12% +$2.27M 0.02% 666
2017
Q2 		$19.2M Buy
189,893
+2,767
+1% +$298K 0.02% 663
2017
Q1 		$21.6M Buy
187,126
+4,147
+2% +$482K 0.02% 638
2016
Q4 		$22M Buy
+182,979
New +$20.3M 0.02% 619

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Legal & General Group's CLB Position: Q2 2026 in Review

Legal & General Group increased its Core Laboratories (CLB) stake by 2.9% in Q2 2026, buying an estimated $48.5K and bringing the position to 122,575 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

Legal & General Group first reported a position in CLB in Q4 2016 and has held it in 38 quarters since. The position peaked at $22.6M in Q4 2017. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Legal & General Group held 122,575 shares of Core Laboratories worth $1.43M as of Q2 2026.
  • Legal & General Group bought 3,397 Core Laboratories shares in Q2 2026, an estimated $48.5K.
  • Core Laboratories made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2080 holding.
  • Legal & General Group first reported a position in Core Laboratories in Q4 2016 and has held it in 38 quarters since.
  • Legal & General Group's Core Laboratories position peaked at $22.6M in Q4 2017.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.